In addition, Wong, H.L. et al. identified a homozygous pathogenic TP53 mutation, a gene fusion event involving APC and MYCN amplification in a resistant PanNETs [48]; however, the primary tumor was not tested for TP53 alterations. The gene discussed is TP53; the disease is neoplasm.